Atamyo Therapeutics
Description: Atamyo develops safe, effective gene therapies for neuromuscular diseases, leveraging AAV expertise from Genethon to treat limb-girdle muscular dystrophies.
Country: France
Based in: Paris
Founded: 2020
Funding Stage: Seed
Tags: ['Biotechnology', 'Genetics', 'Medical', 'Neuroscience']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
